Paper appears to address improving the reliability of AI chatbots for supporting Parkinson's disease patients and future care models, but provides no abstract or mechanistic/therapeutic details.

Improving chatbot dependability could help patient monitoring, education, and adherence, but it offers minimal direct insight or actionable leads for disease-modifying therapies or biomarkers.